114 related articles for article (PubMed ID: 38674157)
21. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
Cebulla CM; Jockovich ME; Piña Y; Boutrid H; Alegret A; Kulak A; Hackam AS; Bhattacharya SK; Feuer WJ; Murray TG
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5215-21. PubMed ID: 18614803
[TBL] [Abstract][Full Text] [Related]
22. MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN.
Zhang Y; Zheng A
J Biochem; 2021 Oct; 170(2):195-202. PubMed ID: 34562091
[TBL] [Abstract][Full Text] [Related]
23. Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma.
Miroschnikov N; Dräger O; Van Meenen D; Metz K; Budeus B; Dünker N; Busch MA
J Oncol; 2023; 2023():2270097. PubMed ID: 36993823
[TBL] [Abstract][Full Text] [Related]
24. Effects of lentivirus-mediated astrocyte elevated gene-1 overexpression on proliferation and apoptosis of human retinoblastoma cells.
Bai H; Chang Y; Li B; Mao Y; Jonas JB
Acta Ophthalmol; 2019 May; 97(3):e397-e402. PubMed ID: 30694025
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p.
Zhang T; Yang J; Gong F; Li L; Li A
Cell Cycle; 2020 Sep; 19(18):2270-2280. PubMed ID: 32772636
[TBL] [Abstract][Full Text] [Related]
26. MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1.
Yang H; Huang Y; He J; Chai G; Di Y; Wang A; Gui D
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32401301
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6.
Wang J; Wang X; Li Z; Liu H; Teng Y
FEBS J; 2014 Mar; 281(5):1355-1365. PubMed ID: 24289859
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
29. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.
Huang Y; Xue B; Pan J; Shen N
Exp Mol Pathol; 2021 Jun; 120():104637. PubMed ID: 33844975
[TBL] [Abstract][Full Text] [Related]
30. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
[TBL] [Abstract][Full Text] [Related]
31. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion.
Guihurt Santiago J; Burgos-Tirado N; Lafontaine DD; Mendoza Sierra JC; Camacho RH; Vecchini Rodríguez CM; Morales-Tirado V; Flores-Otero J
BMC Cancer; 2021 Jan; 21(1):53. PubMed ID: 33430814
[TBL] [Abstract][Full Text] [Related]
32. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.
Dräger O; Metz K; Busch M; Dünker N
Mol Oncol; 2022 Feb; 16(4):957-981. PubMed ID: 34228897
[TBL] [Abstract][Full Text] [Related]
33. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma.
Kakkassery V; Gemoll T; Kraemer MM; Sauer T; Tura A; Ranjbar M; Grisanti S; Joachim SC; Mergler S; Reinhard J
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409416
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
Wu S; Ai N; Liu Q; Zhang J
Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
Song D; Diao J; Yang Y; Chen Y
Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
[TBL] [Abstract][Full Text] [Related]
36. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Fang D; Lai Z; Wang Y
Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TP73-AS1 down-regulates
Xia Z; Yang X; Wu S; Feng Z; Qu L; Chen X; Liu L; Ma Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015368
[TBL] [Abstract][Full Text] [Related]
39. microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a.
Lyu X; Wang L; Lu J; Zhang H; Wang L
Oncol Rep; 2019 May; 41(5):3137-3147. PubMed ID: 30896857
[TBL] [Abstract][Full Text] [Related]
40. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
